Re Health House International Limited

Link copied
Case Copied 35 min read

JURISDICTION     :   SUPREME COURT OF WESTERN AUSTRALIA

IN CHAMBERS

CITATION:   RE HEALTH HOUSE INTERNATIONAL LIMITED; EX PARTE HEALTH HOUSE INTERNATIONAL LIMITED [2023] WASC 133

CORAM:   HILL J

HEARD:   21-22  MARCH 2023

DELIVERED          :   22 MARCH 2023

PUBLISHED           :   28 APRIL 2023

FILE NO/S:   COR 30 of 2023

MATTER:   IN THE MATTER OF HEALTH INTERNATIONAL LIMITED

EX PARTE

HEALTH HOUSE INTERNATIONAL LIMITED

Plaintiff


Catchwords:

Corporations law - Scheme of arrangement - Application for orders convening scheme meeting under s 411(1) of the Corporations Act 2001 (Cth) - Whether requirements to order scheme meeting are satisfied - Orders made convening scheme meeting

Legislation:

Corporations Act 2001 (Cth) s 411(1), s 412(1)(a), s 1319
Corporations Regulations 2001 (Cth) sch 8
Supreme Court (Corporations) (WA) Rules 2004 (WA) r 3.2

Result:

Orders made convening scheme meeting

Category:    B

Representation:

Counsel:

Plaintiff : A J Papamatheos

Solicitors:

Plaintiff : Blackwall Legal

Case(s) referred to in decision(s):

Re Amcom Telecommunications Ltd [2015] FCA 341

Re APN News & Media Ltd [2007] FCA 770; (2007) 62 ACSR 400

Re CannPal Animal Therapeutics Ltd [2021] WASC 37

Re CSR Ltd [2010] FCAFC 34; (2010) 183 FCR 358

Re David Jones Ltd [No 2] [2014] FCA 720; (2014) 101 ACSR 381

Re Doray Minerals Ltd [2019] WASC 57

Re DUET Management Company 1 Ltd [2013] NSWSC 817; (2013) 95 ACSR 34

Re Investa Properties Ltd [2007] FCA 1104

Re Kangaroo Resources Ltd [2018] WASC 327

Re Macquarie Private Capital A Ltd [2008] NSWSC 323

Re Nusantara Resources Ltd [2021] WASC 334

Re Nzuri Copper Ltd [2019] WASC 189

Re Oklo Resources Ltd [2022] WASC 289

Re Opes Prime Stockbroking Ltd [2009] FCA 813; (2009) 179 FCR 20

Re Ozgrowth Ltd [2022] WASC 107

Re Pacific Energy Limited [2019] WASC 443

Re PetroNor E&P Ltd [2021] WASC 426

Re Piedmont Lithium Ltd [2021] WASC 76

Re Saracen Mineral Holdings Ltd [2020] WASC 483

Re Scarborough Equities Ltd [No 2] [2009] FCA 484

Re SRG Ltd [2018] FCA 1092

Re Swick Mining Services Ltd [2022] WASC 79

Re Wesfarmers Ltd [2018] WASC 308

Re Wesfarmers Ltd [No 2] [2018] WASC 357

Re Western Areas Ltd [2022] WASC 193

HILL J:

  1. The plaintiff, Health House International Limited (Health House), is an Australian public company listed on the Australian Securities Exchange (ASX).  On 20 November 2022, Health House entered into a Scheme Implementation Deed (SID) with Creso Pharma Limited (Creso) (Scheme).[1]  Under the Scheme, it is proposed that each shareholder would receive one fully paid ordinary share in Creso and 0.25 of a fully paid option in Creso for approximately every 2.9 fully paid shares held in Health House, subject to an adjustment based on the amount then owing under a Loan Facility Agreement entered into between the parties (Scheme Consideration).  If the Scheme is implemented, Health House will become a wholly owned subsidiary of Creso.

    [1] Affidavit of David Colin Wheeler filed 28 February 2023 'DCW26'.

  2. By an originating process dated 28 February 2023, Health House…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Re Health House International Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2023] WASC 133
Decision Date

CaseChat Overview and Summary

Health House International Limited (Health House), an Australian public company listed on the Australian Securities Exchange, sought orders convening a meeting of its members to consider a proposed scheme of arrangement with Creso Pharma Limited (Creso). Health House and Creso entered into a Scheme Implementation Deed, under which each shareholder would receive one fully paid ordinary share in Creso and 0.25 of a fully paid option in Creso for approximately every 2.9 fully paid shares held in Health House. If the Scheme is implemented, Health House will become a wholly owned subsidiary of Creso. Hill J heard the application on 21 and 22 March 2023. The court found that the formal requirements for convening a scheme meeting under s 411(1) of the Corporations Act 2001 were satisfied. The court also found that the proposed scheme was of a nature that, if it received the necessary statutory majority at the scheme meeting, the court would be likely to approve it. The court was satisfied that there would be proper disclosure as to the effect of the proposed Scheme and the material considerations for shareholders of Health House. The court found that the proposed scheme was fit for consideration by Health House's members. Accordingly, the court made orders convening a meeting of Health House's members to consider and vote on the proposed Scheme.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established